HTML Preview Corporate Compliance Report page number 1.
ANNEXURE-XI
Compliance Report on Corporate Governance.
Name of the Company: Bal Pharma Limited (Scrip Code: 524824)
Quarter ended on : 31.03.2015.
Particulars Clause of Listing
Agreement..
Compliance Status
Yes /No/N.A
Remarks
II. Board of Directors 49(II)
A) Composition of
Board
49(IIA) Yes The Composition of the
Board is in Compliance
with Clause 49(IIA). The
Board has appointed
Ms.Sarika Bhandari as
additional Director of the
company with effect
from 27.03.2015.
B) Independent
Directors
49(IIB) Yes
C) Non Executive
Directors Compensation
& Disclosures
49(IIC) Yes
D) Other provisions as to
Board and Committees.
49(IID) Yes
E) Code of Conduct 49(IIE) Yes Code of conduct is in
place.
F) Whistle Blower
Policy.
49(IIF) Yes Whistle Blower Policy is
in place.
III. Audit Committee 49(III)
A) Qualified &
Independent Audit
Committee
49(IIIA) Yes Audit Committee is in
place.
B) Meeting of Audit
Committee
49(IIIB) Yes
C) Powers of Audit
Committee
49(IIIC) Yes
D) Role of Audit
Committee
49(IIID) Yes
E) Review of
information by Audit
Committee.
49(IIIE) Yes
IV. Nomination and
Remuneration
Committee
49(IV) Yes The remuneration
committee of the
Company is
reconstituted as
Nomination and
Remuneration
Committee.
V. Subsidiary
Companies
49(V) NA Bal Pharma do not have
any material subsidiaries
as on 31.03.2015.
VI. Risk Management 49(VI) Yes Risk management policy
is in place.
VII. Related Party 49(VII) Yes